We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Healthcare 15.36%
3 Financials 15.12%
4 Consumer Discretionary 11.34%
5 Industrials 11.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LW icon
401
Lamb Weston
LW
$7.19B
$614K 0.03%
9,219
+2,400
+35% +$165K
UGI icon
402
UGI
UGI
$7.33B
$611K 0.03%
11,006
+2,900
+36% +$156K
RTX icon
403
RTX Corp
RTX
$301B
$610K 0.03%
6,928
+2,225
+47% +$187K
TOL icon
404
Toll Brothers
TOL
$14.5B
$604K 0.03%
18,300
+4,130
+29% +$149K
MKSI icon
405
MKS Inc
MKSI
$20.6B
$603K 0.03%
7,525
+1,650
+28% +$151K
PWR icon
406
Quanta Services
PWR
$101B
$602K 0.03%
18,030
+4,700
+35% +$160K
STE icon
407
Steris
STE
$23.1B
$601K 0.03%
+5,250
New +$594K
REG icon
408
Regency Centers
REG
$14.1B
$597K 0.03%
9,236
+3,150
+52% +$201K
LOGM
409
DELISTED
LogMein, Inc.
LOGM
$597K 0.03%
+6,700
New +$606K
NKTR icon
410
Nektar Therapeutics
NKTR
$2.58B
$591K 0.03%
647
+197
+44% +$168K
WST icon
411
West Pharmaceutical
WST
$24.9B
$590K 0.03%
4,775
+1,250
+35% +$140K
WTFC icon
412
Wintrust Financial
WTFC
$10.7B
$590K 0.03%
6,950
+1,800
+35% +$160K
THO icon
413
Thor Industries
THO
$4.14B
$586K 0.03%
+7,000
New +$670K
DRE
414
DELISTED
Duke Realty Corp.
DRE
$580K 0.03%
20,449
+5,800
+40% +$166K
DVA icon
415
DaVita
DVA
$11.7B
$578K 0.03%
8,070
-4,620
-36% -$327K
UMPQ
416
DELISTED
Umpqua Holdings Corp
UMPQ
$575K 0.03%
27,650
+15,500
+128% +$339K
UDR icon
417
UDR
UDR
$12.3B
$574K 0.03%
14,205
+4,100
+41% +$160K
LNT icon
418
Alliant Energy
LNT
$18B
$572K 0.03%
13,446
+3,850
+40% +$165K
EVR icon
419
Evercore
EVR
$11.8B
$568K 0.03%
5,650
+1,300
+30% +$140K
HEI.A icon
420
HEICO Corp Class A
HEI.A
$37.2B
$568K 0.03%
7,521
+3,798
+102% +$262K
FIVE icon
421
Five Below
FIVE
$13.5B
$566K 0.03%
4,350
+2,150
+98% +$239K
RPM icon
422
RPM International
RPM
$15B
$562K 0.03%
8,650
-3,800
-31% -$245K
ARRS
423
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$561K 0.03%
21,600
+5,200
+32% +$133K
COHR
424
DELISTED
Coherent Inc
COHR
$560K 0.03%
3,250
+1,025
+46% +$180K
ASB icon
425
Associated Banc-Corp
ASB
$5.91B
$558K 0.03%
21,480
+5,700
+36% +$156K

Similar funds

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.